Jentadueto (linagliptin and metformin hydrochloride) — NDC 0597-0147 by Boehringer Ingelheim Pharmaceuticals, Inc.
Jentadueto (linagliptin and metformin hydrochloride) — NDC 0597-0147 by Boehringer Ingelheim Pharmaceuticals, Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: Jentadueto; Generic name: linagliptin and metformin hydrochloride; Product NDC: 0597-0147.
| Brand name | Jentadueto |
|---|---|
| Generic name | linagliptin and metformin hydrochloride |
| Product NDC | 0597-0147 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Active ingredients | LINAGLIPTIN 2.5 mg/1; METFORMIN HYDROCHLORIDE 850 mg/1 |
| Pharmacologic class | Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA] |
| Marketing category | NDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →